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Abstract
Composite cements have been shown to be
biocompatible, bioactive, with good mechani-
cal properties and capability to bind to the
bone. Despite these interesting characteristic,
in vivo studies on animal models are still
incomplete and ultrastructural data are lack-
ing. The acquisition of new ultrastructural
data is hampered by uncertainties in the meth-
ods of preparation of histological samples due
to the use of resins that melt methacrylate
present in bone cement composition. A new
porous acrylic cement composed of polymethyl-
metacrylate (PMMA) and ?-tricalciumphos-
phate (?-TCP) was developed and tested on an
animal model. The cement was implanted in
femurs of 8 New Zealand White rabbits, which
were observed for 8 weeks before their sacri-
fice. Histological samples were prepared with
an infiltration process of LR white resin and
then the specimens were studied by X-rays,
histology and scanning electron microscopy
(SEM). As a control, an acrylic standard
cement, commonly used in clinical procedures,
was chosen. Radiographic ultrastructural and
histological exams have allowed finding an
excellent biocompatibility of the new porous
cement. The high degree of osteointegration
was demonstrated by growth of neo-created
bone tissue inside the cement sample. Local or
systemic toxicity signs were not detected. The
present work shows that the proposed proce-
dure for the evaluation of biocompatibility,
based on the use of LR white resin allows to
make a thorough and objective assessment of
the biocompatibility of porous and non-porous
bone cements.
Introduction
In orthopedic clinic, polymethylmetacrylate
(PMMA) was first used for prostheses fixation
and as a bone substitute.1 More recently, the
indications to the use of this material have
been extended to transpedicular vertebroplas-
ty,2 osteoporotic compression fractures3-7 and
screws augmentation.8 All PMMA-based
cements have excellent mechanical properties,
radiopacity and generally are easy to use.9. The
negative characteristics of PMMA-based bone
cements are the strongly exothermic reaction,
toxic effects of the monomer, inability to bind
to bone and eventual induction of foreign body-
granulomas.10-12 The development of a fibrous
tissue layer at the interface and bone reabsorp-
tion was also described.13,14 In order to avoid
the disadvantages linked to the use of PMMA,
new generations of bioactive bone cements
have been developed.15 Calcium phosphate-
based cement (CPC) has been tested and clin-
ically used as bony filler in traumatic bone loss
for its excellent self-setting ability, biocompat-
ibility, partial osteoconductivity and biore-
sorbability. However, CPC has poor mechanical
characteristics (e.g., compression strength). In
addition, its handling problems and limited
radiopacity prevents extended clinical uses.16-21
Composite cements (i.e., a mixture of acrylic
cement and a ceramic component) have been
shown to be biocompatible, bioactive and with
good mechanical properties.22,23 In general,
these materials demonstrate improved capabil-
ity to bind to the bone.24 Despite these interest-
ing characteristic, in vivo studies on animal
models are still incomplete and, in particular,
ultrastructural data are lacking. Information
about such a structural organization cannot be
obtained by means of biochemical techniques
or optical microscopy, but requires ultrastruc-
tural evaluations, as demonstrated for adipose
tissue.25 Ultrastructural data can be useful to
understand the mechanisms of interaction
between cements and the host tissue and to
evaluate more correctly the suitability of
cements for a particular purpose. 
In the present study, we have developed a
new procedure for testing acrylic cements in
an in vivo animal model. For this purpose, we
have used a new porous acrylic cement com-
posed of PMMA and ?-tricalciumphosphate (?-
TCP).26,27 The study was conducted by an
experimental procedure that allows to avoid
uncertainties in the methods of preparation of
histological samples due to use of chemicals
that melt methacrylate present in bone cement
composition. The method that we propose is
based on an embedding in LR white resin,
which is more commonly used in histochemi-
cal studies. This approach improves the visual-
ization of the bone-cement interface adding
new data on the behavior of an important com-
ponent of therapy.
Materials and MethodsBone cements
Two types of bone cement were used, both
made from PMMA and ?-TCP but with different
physical-chemical characteristics. For the con-
trol group, it was assumed to use cement with
balanced chemical, biological and physical
characteristics, widely used in clinical prac-
tice. To meet these requirements, we chose a
cement used in vertebroplasty as Mendec®
Spine (Tecres SpA, Sommacampagna, Italy)
(NP cement). For the experimental group, a
cement was realized, which present the char-
acteristics of porosity, with the purpose of
studying the behavior of bone tissue from the
ultramicroscopic point of view (Porosectan®
Tecres SpA) (P cement). Cements have been
formulated and used in both liquid and in pow-
der preparation and their composition is
shown in Table 1.
All experiments were performed according to
the following ISO norms: UNI EN ISO 10993-6
(2007): Test of local effects after implantation;
UNI EN ISO 10993-1 (2004): Biological evalua-
tion of medical devices. Part 1 Evaluations and
testing; and UNI EN ISO 10993-12 (2005):
Sample and reference materials.Animal experiments
Cements were implanted in New Zealand
White (NZW) rabbits, which were sacrificed
after eight weeks. The animals used were eight
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female rabbits weighting between 2.9 Kg and
3.6 Kg before the beginning of the study. The
rabbits were reared and operated at the
Interdepartmental Center of Scientific
Research on Laboratory Animals (Centro
Interdipartimentale per la Ricerca Scientifica
su Animali da Laboratorio, CIRSAL, University
of Verona). The breeding conditions were in
accordance with the European Directives (CE
Directive 86/609) and UNI EN ISO 10993-2
(2006): Animal welfare requirement. The rab-
bits were bred in an individual metallic cage
(Tecniplast®, according to D.Lgs 116/02) and fed
with complete granular diet for rabbits, ad libi-
tum. Water was freely accessible. Temperature
was between 15° to 21°C and room relative
dampness was between 30% to 70%. The opera-
tive staff was qualified and educated. Both
femurs of each rabbit were operated in different
operating times, 2 weeks apart one after the
other, in order to reduce the toxicity due to the
anesthesia and to an excessive dosage of the
acrylic cement. The NP cement was injected in
the right femur whereas the new experimental
cement into the left femur after 2 weeks.Animal preparation and anesthesia
After trichotomy of concerned area, the rab-
bit was brought into operating room and posi-
tioned supine on the operating table. General
anesthesia induction was carried out by a vet-
erinarian, with intramuscular injection of an
association of tiletamine hydrochloride and
zolazepam hydrochloride (Zoletil 100®) at a
dose of 20 mg/Kg and Xylazione (Rompun®) at
a dose of 5 mg/Kg. A local anesthesia with lido-
caine was also injected in the site of the surgi-
cal incision.Surgical procedures
After washing, disinfection and preparation
of sterile operating field, we made a longitudi-
nal skin incision on lateral surface of femoral
condyle, with exposition of troclea gorge, after
patellae dislocation. The region was then
washed with physiological saline. The femoral
bone marrow channel was drilled with sterile
electrical drill (Ø 4 mm, dept 3-4 cm). After
drilling, we washed and cleaned the hole to
remove every bone parts created. We filled the
femoral cavity with 0.5-1 cc of acrylic cement
with an appropriate syringe (the cement was
injected in femoral distal epiphysis where cor-
tical and spongious bone tissues were pres-
ent). We reduced the dislocation and we did
articular capsule suture with reabsorbable
spin or Vicryl® n° 3-0 and skin suture with not
reabsorbable spin Prolene® n° 3-0. We made an
elastic adhesive bandage, after final disinfec-
tion. Analgesic therapy with Altadol® IM (4
mg/Kg) was administrated to the rabbits, after
that the animals were located under UV lamp
for 10 min, before returning in their cage.
Post-operative clinical follow-up
Animals were observed daily to detect clini-
cal abnormalities and antibiotic therapy was
administrated for four days (Baytril® 2.5% SC 5
mg/Kg). Medications with antiseptic iodate
(Braunol®) were done, and 10 days after sur-
gery, cutaneous stitches are removed.
The rabbits state of well-being was assessed
with physiological elements (feeding, stool
and urine), physical elements (functions of
operated limb and coat growth) and behavior
elements, like open field. This test, known as
escape test, is an indication of fear response
(rabbit is prey animal, with avoidance reac-
tions, like fear of new situations and human
presence).Animals sacrifice
Rabbits were sacrificed through pharmacol-
ogy euthanasia with a lethal injection of
Tanax® after 8 weeks. Femurs were extracted
from thigh, bone curettage from soft tissues
was carried out and then all bones were put
inside a transparent sterile envelope.Radiographic examination
A radiographic examination was carried out
using a Philips Practix 360 mobile radiography
system. It consisted of antero posterior and lat-
eral side of left and right femur of each rabbit.Ultrastructural analysis of cementporosity
With the purpose of comparing their physi-
cal structure, cements were subjected to struc-
tural analysis with scanning electron micro-
scope (SEM), which has a high depth of field
and allow a good visualization of eventual
porosity. To obtain a correct analysis of the sur-
face, the samples were maintained under vac-
uum (10-5 Torr) and covered by a layer of con-
ductive metal to avoid electrostatic charge.
Therefore, samples were covered with a thin
layer of gold by a sputtering coater MED 010
(Balzers). A DSM 950 (Zeiss) SEM was used
for ultrastructural examination.Histological samples preparation
Rabbit’s femurs were fixed in buffered
formaldehyde (pH=7) for 3 days. Every femur
distal third was pulled out and treated with
resin inclusion according to the following pro-
tocol:
- progressive dehydration in ethyl alcohol at
progressive gradation (50%, 70%, 80%, 95%,
absolute) leaving the sample for at least 3
days in every alcohol, three passage in
absolute ethanol;
- infiltration with LR white resin, three pas-
sages for a total time of 15 days.
- resin polymerization.
Since all resins, used for the infiltration
required for histological cutting, dissolved the
methacrylate used in the cement, we searched
for a resin allowing cement to resist and do not
dissolve under long infiltration periods. For
this purpose, we chose LR white resin and an
infiltration time compatible with inclusion
quality has been established as mentioned
above. The samples were cut by a circular
microtome for bone (Leitz 1660) according to a
plane perpendicular to the femur axis obtain-
ing 100 µm thick sections. These sections
were stained by immersion in a blue of tolui-
dine solution (basic color that evidence cellu-
lar nucleus and cartilage) for 5 min and, after
water washing, they were immersed in a fast
green solution (color that evidences the bone)
for 2 min. After further water washing, the sec-
tions were quickly dehydrated by immersion in
progressive graded alcohol solutions. After this
operation, sections were put on slide holders
with DPX for optical microscope observation.
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Table 1. Tested bone cements composition and some chemical-physical characteristics.
Cements
Non porous cement   Porous cement 
or NP cement or P cement
(Mendec ® Spine) (Porosectan®)
Powder package 20 g powder 20 g powder
Powder composition - Polymethylmetacrylate 67.5% - Polymethylmetacrylate 65.0%
- Barium solphate 30,0% - ?-TRICALCIUM PHOSPHATE 30.0%
- Benzoyl peroxide 2.50% - Barium sulphate 5.0%
Liquid package 9.4 g phial 5.0 g phial
Liquid composition - Methylmetacrylate 99.10% - Methylmetacrilate 98.20%
- N-N dimethyl-p-toluidines 0.90% - N-N dimethyl-p-toluidines 1.80%
- Hydroquinone 75 ppm - Hydroquinone 75 ppm
Setting time 21-25 min 9 min
Max. polimerization temperature 70°C 44°C
Max water absorption 3% 20%
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Evaluation of osteoconductivity
All samples were examined under an optical
microscope (Eclipse 80i, Nikon). For this exam-
ination, the middle section of each series
obtained from the area filled with cement was
used. Regenerated bone was distinguished
from original based on histological features,
namely the staining and different morphologies
of bone cells and matrix. Computer-assisted his-
tomorphometric measurements of the implant-
ed cements and soft tissues were also per-
formed using an image analyzer (Image J,
NIH). The affinity index of each cement was cal-
culated on basis of regenerated bone areas as a
percentage of the total cement area. The data
obtained were compared using one-way analy-
sis of variance (ANOVA). P-values <0.05 were
considered statistically significant.28
ResultsChemical-physical and mechanicalperformances of cements
The ISO 5833 norm was followed to describe
the chemical-physical performances (Table 1)
and static mechanical performances (Table 2)
of both medical devices. Water absorption was
also calculated evaluating the increase in
weight following 30 min of immersion in saline
solution. P cement has a quicker setting time
(9’ vs 21’-25’), a lower polymerization tempera-
ture (44°C vs 70°C) and higher water absorp-
tion (20% vs 3%) compared to NP cement. 
Static mechanical performances of P cement
are markedly lower compared to NP cement:
compression 50MPa vs 100 MPa, bending
strength 22 MPa vs 50 MPa and bending modu-
lus 900 MPa vs 3100 MPa.Clinical follow-up
The surgery procedure was well-tolerated and
the animals managed to feed himself since the
day after the operation. Within a few days, they
managed to move again inside the cage. The
effects due to the introduction of the cement
and to his following polymerization were
hypotension/low heart rate: these effects have
been noticed during the surgery session and
were similar for both the bone cements. Neither
signs of local swelling or inflammation, nor sys-
temic signs of cement-toxicity or allergic reac-
tions were found. All the animals subjected to
the operation survived.Macroscopic examination
After the removal of the femur, the injection
area was well-visible. To the touch, the surface
of the P cement appeared rougher than those of
NP cement. In addition, the surface P cement
could easily be scratched with the scalpel.
Radiographic examination
In NP cement samples, post-mortem radi-
ographic examination of the removed femurs
demonstrated, a reduced radio-opacity, proba-
bly due to the lower quantity of barium (Figure
1 A,B). In P cement scaffold there were granu-
lous-like radio-opaque spots resembling to NP
cement specimens implanted in the other
femur. These radio-opaque spots, resembling
NP cement in term of density, were probably
due to the presence of PMMA. In fact, the other
component of the NP cement (i.e., the ?-TCP)
is rapidly reabsorbed being quickly dissolved
(more than hydroxyapatite present in other
cements) and it is partially substituted by bone
tissue, whereas PMMA is not reabsorbable. Scanning electron microscopeobservations
At scanning electron microscope (SEM)
examination, P cement’s surface resulted very
porous and characterized by a stringy appear-
ance, with interconnected volumes and with
the presence of many microreliefs, cavities
and pores (Figure 2 A,B). Typical spherical par-
ticles, characterized by a diameter of about 40
?m, were evident inside the cement agglomer-
ation. Probably, they were particles of PMMA,
previously treated because of their incompati-
bility with tricalcium-phosphates. In P cement,
micropores and macropores characterize the
surface. The average diameter of the microp-
ores varies from 10 to 15 ?m; the macropores
go from 100 to 250 ?m. It could be remembered
that a similar situation exists in the spongious
bone where trabeculae are within about 200-
300 ?m one another. On the contrary, as we
can notice from the pictures (Figure 3 A,B), NP
cement’s surface results solid, predominantly
sleek and with a rare presence of pores: the
gaps, evident on the surface, are probably arti-
facts due to the technical treatments.  Evaluation of osteoconductivity
The affinity indices (%) for the P cement
and the NP cement at each month are shown
in the graph (Figure 4). Their averages were
80.01 (±4.3) and 21.24 (±1.8), respectively.
These differences were statistically significant
(P>0.01).
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Table 2. Tested bone cements mechanical properties compared to mature bone.
Cements Compression strength Bending strength Bending modulus
NP cement 100 MPa ± 8 MPa 50 MPa ± 5 MPa 3100 MPa
P cement 50 MPa ± 8 MPa 22 ± 5 mpA 90 MPa
Mature bone Femur 167 MPa Not applicable 6000 MPa
Humerus 130 MPa
Vertebra 7 MPa
Figure 1. X-rays: antero posterior (A) and lateral side (B) of right (R) and left (L) femur.
Left femur (L) with the P cement and right femur (R) with NP cement. In NP cement
samples, post-mortem radiographic examination of the removed femurs demonstrated a
reduced radio-opacity, probably due to the lower quantity of barium (white circle). In P
cement scaffold there were granulous-like radio-opaque spots resembling to NP cement
specimens implanted in the other femur (red circle).
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Histological examination
As expected, LR white resin the resin did not
melt the methacrylate in the infiltration treat-
ment. It was not possible to cut sections thin-
ner than 100 ?m, and some sections are came
unstuck during the cut. Because DPX and
xylene, indispensable to create the slides, melt
the cement, cement casting out of its limit was
found in some slides. However, areas close to
cement, were well preserved and surface color
allowed to evaluate tissues near to the cement. 
Histological analysis allowed to distinguish,
on the basis of their density, the acrylic cement
(NP cement) (Figure 5 A,B) from the P cement
(Figure 5 C,D); the first presented a structure
denser and more homogeneous than the sec-
ond, which showed a more inhomogeneous
and irregular structure. In the histological sec-
tions, in both the cements, the outline of the
hole, made with the operating drill, appeared
always evident (Figure 5 A,C). The cement
resulted regularly and clearly surrounded by
circular-course trabeculae of bone (rather than
radial-course ones visible in absence of
cement). These features demonstrate that new
bone tissue is formed around the cement.
Some trabeculae of bone and neo-created
areas of connective tissue were also evident in
P cement. They penetrated the superficial
pores of the cement (Figures 6 A,B, 7, 8 A-C).
These structures entered the cement for about
250 ?m average in depth (Table 3). The meas-
ures made in these areas demonstrated that
the bone keeps on growing until a depth of
maximum 400 ?m. The observation under
polarized light confirmed that it is actually
bone tissue and not an artifact due to the tolu-
idine blue, which sometimes penetrates the
cavities giving the impression that the neo-
created bone stays inside the cement (Figure 6
A,B). According to the size of the bone-filled
cavities, there was evidence that their diame-
ter varies approximately from 30 ?m to 150
?m: these holes almost correspond to the
dimensions of the cement’s superficial cavities
visible at SEM examination. The osteoconduc-
tivity of P cement, due to its open macroporous
structure, allowed the bone cells and the blood
vessels to colonize superficially the bone gap
left by the P cement reabsorption; it also prob-
ably permitted to the osteoblasts to re-create
homogeneously the bone tissue only at the
bone-cement interface (Figure 6A).
The sample of NP cement, according to its
low porosity, did not show penetration of any
type of material. Moreover, around the samples
where the P cement was used, there was no
result of any bone or connective tissue prolifer-
ation. This aspect was probably due to the high
density of the material that allowed only a limit-
ed penetration of fibrous tissue in rare micros-
plits (Figure 7). In P cement, the presence of
stained areas, which go deeper from the outside
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Figure 2. SEM examinations of P cement surface. P cement surface resulted very porous
and characterized by a stringy appearance, with interconnected volumes and with the
presence of many microreliefs (red circles), cavities (violet circles) and pores (green cir-
cles). Typical spherical particles, characterized by a diameter of about 50 ?m, were evi-
dent inside the cement agglomeration. In P cement, the surface is characterized by micro-
pores and macropores. Scale bars: A), 100 µm; B), 20 µm.
Figure 3. SEM examinations of NP cement surface. NP cement surface results solid, pre-
dominantly sleek and with a rare presence of pores (green circles): the gaps, evident on
the surface, are probably artifacts due to the technical treatments. Scale bars: A), 250 µm;
B), 50 µm.
Figure 4. Affinity indices of the P cement and the NP cement in 8 rabbit samples. The
average value were 80.01 and 21.24, with a standard deviation of 12.24 and 6.04, respec-
tively for P cement and NP cement.
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to the central zone (Figure 8 A-C), indicates the
porosity of the cement, but it was not clear if
osteoblasts penetrated in the cement from near-
ly bone or if they are generated by a prolifera-
tion inside the matrix (bone neo-creation). It
has to be noticed that P cement did not show
superficial pores in the entire bone-cement
interface. In some areas the surface appeared
devoid of pores: in these areas, the surrounding
bone behaves as it does around NP cement (i.e.,
it did not penetrate the cement). Probably, this
result was due to the superior density of PMMA
belonged to these zones. A reasonable explica-
tion of this superior density is that PMMA did
not amalgamate well during the mixing of the
cement. About the analysis of the soft tissues, it
is important to underline that the type of tech-
nical approach used in this study has not
allowed keeping them well-preserved in all the
areas. In this research, the preservation of the
cement and of the bone was privileged. Anyway,
the observation of the areas that resulted less
damaged by the resin indicated that the
cements used cause neither necrosis nor
inflammation of the surrounding soft tissues. In
both the analyzed samples, there was generally
no evidence of any significant inflammatory
reaction, necrosis or fibrosis of the surrounding
bone tissue.
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Table 3. Samples histological evaluation: osteointegration and cement penetration depth
in bone.
N. NP cement P cement Penetration depth 
Right femur Left femur of cement
1 Osteointegration Osteointegration + superficial 215±35 ?m
penetration of bone in some 
circumferential areas
2 Osteointegration Osteointegration + superficial 330±70 ?m
penetration of bone 
in some circumferential areas
3 Osteointegration Osteointegration + superficial 150±29 ?m
penetration of bone 
in some circumferential areas
4 Osteointegration Osteointegration + superficial 244±41 ?m
penetration of bone 
in some circumferential areas
5 Osteointegration Osteointegration + superficial 277±55 ?m
penetration of bone 
in some circumferential areas
6 Osteointegration Osteointegration + superficial 240±30 ?m
penetration of bone 
in some circumferential areas
7 Osteointegration Osteointegration + superficial 277±30 ?m
penetration of bone 
in some circumferential areas
8 Osteointegration Osteointegration + superficial 270±49 ?m
penetration of bone 
in some circumferential areas
Figure 5. Histological sample
of NP cement (A), its enlarge-
ment (B), P cement (C) and its
enlargement (D). Histological
analysis allowed to distin-
guish, on the basis of their
density, the NP cement (A, B)
from the P cement (C, D); the
first presented a structure
denser and more homoge-
neous than the second, which
showed a more inhomoge-
neous and irregular structure.
In the histological sections, in
both the cements, the outline
of the hole, made with the
operating drill, appeared
always evident. The cement
resulted regularly and clearly
surrounded by circular-course
trabeculae of bone (rather
than radial-course ones visible
in absence of cement). These
features demonstrate that new
bone tissue is formed around
the cement. Scale bars: A,C),
200 µm. B), 20 µm; D), 40
µm.
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Discussion
Scientific publications relating to the evalua-
tion of the in vivo biocompatibility of cements,
show different approaches and results28-31 and in
the present study we have assessed the biocom-
patibility of porous and non-porous cement. For
this purpose, it is useful to note that signs of
local or systemic toxicity were not found: in par-
ticular, neither inflammation nor infection were
detected in the site of injection and no foreign
body reaction was found. In addition, the histo-
logical examination showed no evidence of
necrosis, inflammation or fibrosis areas.
Therefore, the porous material that we have
used revealed a biocompatibility comparable to
those of traditional acrylic cement. Toxicity due
to an eventual presence of monomer was not
detected. In addition, the low polymerization
temperature of the new material suggests that a
lesser methylmethacrylate concentration than a
traditional acrylic cement could have a role in
decreases the eventual thermal necrosis of bone
nearly the cement. In this site, the porous
cement was surrounded by a layer of bone tis-
sue, which appears to be a result of his low local
toxicity. At radiological examination, its opacity
was not much less than the control (NP
cement), however some differences between the
two cements were found (i.e. the first showed a
showed a granulose texture, while the second
appeared more compact.21 This aspect is proba-
bly related with the structure of this cement that
is microscopically porous with an outbound
opened structure. Through SEM analysis, we
have seen that cement pores are about 150-200
µm diameter and they are interconnected creat-
ing a scaffold like hydroxyapatite in the spon-
gious bone tissue. Therefore, they can be classi-
fied as macropores and they seem to be large
enough to allow the penetrations of cells and
even of vessels from the surrounding tissue. In
addition, we observed the presence of microp-
ores with a 10-15 µm diameter, which form
interconnections between the bigger pores, cre-
ating a tridimensional scaffold that supply fluid
penetration inside the matrix as demonstrated
in vitro studies.32
At the histological examination, we observed
that the porous cement is penetrated by bone-
like matrix but only superficially till to 250 µm
average depth, demonstrating that its ostecon-
ductive property is only limited to the peripheral
areas. We suppose that a deeper penetration of
bone matrix might be considered available with
cement characterised by bigger pores as sug-
gested by Goto et al.22 Despite this limit, the pen-
etration possible because of the bind to bone
characteristic of this cement, which contacted
bone directly without fibrous tissue interposi-
tion is certainly of interest.  The affinity index is
a rate of this characteristic and it considers the
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Figure 6. The presence of stained areas inside the cement at the interface (P cement).
Some trabeculae of bone and neo-created areas of connective tissue were also evident in
?-TCP/acrylic  samples (P cement). They penetrated the superficial pores of the cement.
Scale bars: A), 40 µm; B), 20 µm.
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relationship between all the cement area and
the cement surface in contact directly with bone.
In literature is reported that PMMA-affinity
indices are less than the ones of TCP-based
cements; the present work suggests that this
aspect could be related to the formation of a
fibrous layer between the PMMA surface and
bone, which is typical of a foreign body reaction.
TCP-based cement is partially reabsorbed by
osteoclastic elements and this reaction lead to
the release of calcium and phophorous ions,
which could promote the bone apposition.16 As
regards the affinity index, the results of the
present study are quite consistent with those
obtained by Goto et al.22 Other type of cements,
(e.g., methacrylate cement with AW-glass ceram-
ic, hydroxyapatite or ?-TCP fillers) are described
in literature33,34 binding to bone directly but a
thinner calcium-phosphate rich layer is reached
using these material than using a TCP/acrylic-
based cement. The affinity indices of these
materials are also reported to be lower than
obtained using porous cement giving a measure
of its biocompatibility.
Additional considerations emerge from the
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Figure 7. Histological sample of NP cement. Scale bar: 40 µm.
Figure 8. Histological sample of P cement (A) and enlarged par-
ticulars (B, C). Scale bars: A), 40 µm; B,C), 20 µm.
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analysis of the results. The increase of contact
surface (probably due to the increased porosity
of the cement) and the formation at the bone-
cement interface of newly formed trabecular
bones with strands of connective tissue going
deep into the superficial layer of the cement,
prove the excellent osteointegration of the
cement with the biological structures of the
host. This, together with the low elastic modulus
of the new porous cement, leads to potential
advantages in terms of lighter wearing, greater
elasticity and dynamic resistance to fatigue and
collisions.27 Porous cements made by
TCP/PMMA could be considered for vertebroplas-
tic or augmentation orthopaedics uses, but fur-
ther studies are necessary in order to evaluate
the mechanical properties of this material in
vivo. The use of LR white resin to prepare sam-
ples of bone tissue subjected to injections of
bone cements has proven to be able to obtain
histological images of high quality.
Simultaneously, the use of SEM allows an objec-
tive measure of the pores, eventually present in
the bone cement.  The present work shows that
the proposed procedure for the evaluation of bio-
compatibility, based on the use of LR white resin
and the use of (SEM) allows making a thorough
and objective assessment of the biocompatibility
of porous vs non-porous bone cements.
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